Will Stone
Will Stone is a former reporter at KUNR Public Radio.
-
A Seattle hospital confronts the omicron surge. While COVID-19 patients aren't as sick compared to earlier waves, there is a record number of patients overall, and not enough staff to care for them.
-
Some hospitals report less strain as omicron seems to cause less severe illness. But they're still overcrowded with patients. Research shows death rates rise significantly when hospitals are full.
-
The omicron variant is gaining a foothold in Europe. Scientists say it is spreading faster than delta and can do so even in places where many people are vaccinated. What could this mean for the U.S.?
-
Ahead of the holidays, coronavirus cases are down, but the U.S. remains stuck in a cycle of regional outbreaks, even in heavily vaccinated northern states. Can boosters and kids vaccines make a dent?
-
A medical task force is changing its guidance on the use of aspirin to prevent cardiovascular disease. It says older Americans without heart disease should not start taking daily low dose aspirin.
-
More than 100,000 people in the Unites States are in the hospital for COVID-19. Increasingly, states are again facing decisions about whether they have to ration care.
-
The U.S. and its allies are starting to send about 1 billion doses to Latin America, Africa and Asia. Workers on the ground say there are still big obstacles to making sure vaccines don't go to waste.
-
Loss of smell has become one of the defining symptoms of COVID-19. Scientists have ideas why, but aren't sure how to reverse the damage. Some are trying what's called 'olfactory training.'
-
COVID-19 has plateaued in the U.S., but hospitalizations of young adults are up about 40% since early March. And polls suggest some young adults may not be interested in getting vaccinated.
-
Pausing use of the Johnson and Johnson vaccine looks unlikely to cause major problems in the overall U.S. vaccination effort, but some places counting on those doses are scrambling.